130 related articles for article (PubMed ID: 38796770)
1. Severe adrenal insufficiency in six neonates with normal newborn screening for CAH.
Kurt I; Eser M; Kahveci A; Ucar A; Bulus D; Ozcabi B; Guran O; Karagozlu S; Ersoy A; Demir S; Geckinli B; Guran T
Clin Endocrinol (Oxf); 2024 May; ():. PubMed ID: 38796770
[TBL] [Abstract][Full Text] [Related]
2. Presenting status of children with classical congenital adrenal hyperplasia over two decades (1999-2018) in the absence of newborn screening in Sri Lanka.
Seneviratne SN; Sandakelum U; Jayawardena CH; Weerasinghe AM; Wickramarachchi PS; de Silva S
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1131-1137. PubMed ID: 34192833
[TBL] [Abstract][Full Text] [Related]
3. Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia.
Navardauskaitė R; Banevičiūtė K; Songailienė J; Grigalionienė K; Čereškevičius D; Šukys M; Mockevicienė G; Smirnova M; Utkus A; Verkauskienė R
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684072
[No Abstract] [Full Text] [Related]
4. Characteristics of patients with classic congenital adrenal hyperplasia missed on the newborn screen.
Saroufim R; Nebesio TD; Eugster EA
Horm Res Paediatr; 2023 Nov; ():. PubMed ID: 37992692
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Primary Adrenal Insufficiency: A 21-year Single Center Experience.
Çamtosun E; Dündar İ; Akıncı A; Kayaş L; Çiftci N
J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):88-99. PubMed ID: 32938577
[TBL] [Abstract][Full Text] [Related]
7. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.
Miller WL
Horm Res Paediatr; 2019; 91(6):416-420. PubMed ID: 31450227
[TBL] [Abstract][Full Text] [Related]
8. Devastating salt-wasting crisis in a four-month-old male child with congenital adrenal hyperplasia, highlighting the essence of neonatal screening.
Reddy NA; Sharma S; Das M; Kapoor A; Maskey U
Clin Case Rep; 2022 Jul; 10(7):e6010. PubMed ID: 35846927
[TBL] [Abstract][Full Text] [Related]
9. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
10. International Newborn Screening Practices for the Early Detection of Congenital Adrenal Hyperplasia.
Conlon TA; Hawkes CP; Brady JJ; Loeber JG; Murphy N
Horm Res Paediatr; 2024; 97(2):113-125. PubMed ID: 37231960
[TBL] [Abstract][Full Text] [Related]
11. Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single center 10-year experience.
Bizzarri C; Olivini N; Pedicelli S; Marini R; Giannone G; Cambiaso P; Cappa M
Ital J Pediatr; 2016 Aug; 42(1):73. PubMed ID: 27485500
[TBL] [Abstract][Full Text] [Related]
12. Primary Adrenocortical Insufficiency Case Series in the Neonatal Period: Genetic Etiologies Are More Common Than Expected.
Gao J; Chen L
Front Pediatr; 2020; 8():464. PubMed ID: 32903448
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
14. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
[TBL] [Abstract][Full Text] [Related]
15. Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia.
Sarafoglou K; Banks K; Gaviglio A; Hietala A; McCann M; Thomas W
Pediatrics; 2012 Nov; 130(5):e1261-8. PubMed ID: 23071209
[TBL] [Abstract][Full Text] [Related]
16. Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo.
Morikawa S; Nakamura A; Fujikura K; Fukushi M; Hotsubo T; Miyata J; Ishizu K; Tajima T
Clin Pediatr Endocrinol; 2014 Apr; 23(2):35-43. PubMed ID: 24790385
[TBL] [Abstract][Full Text] [Related]
17. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience].
Cardoso CB; Fonseca AA; Oliveira Mde F; Pereira BB; Guimarães MM
Arq Bras Endocrinol Metabol; 2005 Feb; 49(1):112-9. PubMed ID: 16544042
[TBL] [Abstract][Full Text] [Related]
18. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
Therrell BL; Berenbaum SA; Manter-Kapanke V; Simmank J; Korman K; Prentice L; Gonzalez J; Gunn S
Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
Gong LF; Gao X; Yang N; Zhao JQ; Yang HH; Kong YY
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):253-258. PubMed ID: 30817302
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
